![Michael Ryde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Ryde
Vorstandsvorsitzender bei
Pharmacosmos Therapeutics Inc.
Health Technology
Profil
Michael Ryde is currently the Chief Executive Officer at Pharmacosmos Therapeutics Inc. He previously worked as the Vice President-Sales at Pharmacosmos A.
Aktive Positionen von Michael Ryde
| Unternehmen | Position | Beginn |
|---|---|---|
Pharmacosmos Therapeutics Inc.
 Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Michael Ryde
| Unternehmen | Position | Ende |
|---|---|---|
Pharmacosmos A/S
 Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Vertrieb & Marketing | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Pharmacosmos Therapeutics Inc.
Pharmacosmos Therapeutics Inc. BiotechnologyHealth Technology Develops treatments for patients suffering from iron deficiency and anemia | Health Technology |
